AVGO vs TSHA · P/E 87, rev $63.89B vs $640.7M cap
Broadcom Inc (AVGO) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock E. Tan.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported AVGO revenue for 2025-11-02 was $63.89B. Net income was $23.13B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the AVGO and TSHA stock pages for the full models.
Not investment advice.